StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)

Close on Nov 17, 2026Market cap $2.57BP/E –Yield –

Xencor ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Xencor's ebitda for the twelve months ending Jun 30, 2026 was -$206.23M. For fiscal 2025 it was -$166.99M. The highest annual figure on record is $51.26M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$166.99M–
FY2024Dec 31, 2024-$166.30M–
FY2023Dec 31, 2023-$120.86M–
FY2022Dec 31, 2022-$73.67M-243.7%
FY2021Dec 31, 2021$51.26M–
FY2020Dec 31, 2020-$71.00M-491.8%
FY2019Dec 31, 2019$18.12M–
FY2018Dec 31, 2018-$76.12M–
FY2017Dec 31, 2017-$41.09M-190.3%
FY2016Dec 31, 2016$45.51M–
FY2015Dec 31, 2015-$17.23M–
FY2014Dec 31, 2014-$15.58M–
FY2013Dec 31, 2013-$9.81M–
FY2012Dec 31, 2012-$5.70M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.77M–
Q1 FY2026Mar 31, 2026-$75.30M–
Q4 FY2025Dec 31, 2025-$51.05M–
Q3 FY2025Sep 30, 2025-$45.12M–
Q2 FY2025Jun 30, 2025-$30.77M–
Q1 FY2025Mar 31, 2025-$40.49M–
Q4 FY2024Dec 31, 2024-$10.18M–
Q3 FY2024Sep 30, 2024-$52.40M–
Q2 FY2024Jun 30, 2024-$52.67M–
Q1 FY2024Mar 31, 2024-$51.63M–
Q4 FY2023Dec 31, 2023-$24.12M–
Q3 FY2023Sep 30, 2023-$15.13M–
Q2 FY2023Jun 30, 2023-$23.11M–
Q1 FY2023Mar 31, 2023-$58.50M-304.2%
Q4 FY2022Dec 31, 2022-$40.43M-143.1%
Q3 FY2022Sep 30, 2022-$36.11M–
Q2 FY2022Jun 30, 2022-$25.78M-337.8%
Q1 FY2022Mar 31, 2022$28.64M–
Q4 FY2021Dec 31, 2021$93.76M–
Q3 FY2021Sep 30, 2021-$39.31M–
Q2 FY2021Jun 30, 2021$10.84M–
Q1 FY2021Mar 31, 2021-$14.03M–
Q4 FY2020Dec 31, 2020-$12.17M–
Q3 FY2020Sep 30, 2020-$15.28M–
Q2 FY2020Jun 30, 2020-$36.16M–
Q1 FY2020Mar 31, 2020-$7.40M-109.3%
Q4 FY2019Dec 31, 2019-$29.35M–
Q3 FY2019Sep 30, 2019-$13.21M-1000.2%
Q2 FY2019Jun 30, 2019-$18.57M–
Q1 FY2019Mar 31, 2019$79.24M–
Q4 FY2018Dec 31, 2018-$20.20M-440.3%
Q3 FY2018Sep 30, 2018$1.47M–
Q2 FY2018Jun 30, 2018-$27.47M–
Q1 FY2018Mar 31, 2018-$29.92M–
Q4 FY2017Dec 31, 2017$5.94M–
Q3 FY2017Sep 30, 2017-$23.02M–
Q2 FY2017Jun 30, 2017-$8.06M–
Q1 FY2017Mar 31, 2017-$15.95M–
Q4 FY2016Dec 31, 2016-$9.56M–
Q3 FY2016Sep 30, 2016-$8.88M–

More Xencor figures

See a number that looks wrong?